Brown Advisory’s Alto Neuroscience ANRO Stock Holding History

Brown Advisory’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$562K	Hold	25,000	–	–	﹤0.01%	1020
2025 Q4	$445K	Hold	25,000	–	–	﹤0.01%	1097
2025 Q3	$101K	Hold	25,000	–	–	﹤0.01%	1357
2025 Q2	$55K	Hold	25,000	–	–	﹤0.01%	1341
2025 Q1	$54K	Hold	25,000	–	–	﹤0.01%	1309
2024 Q4	$106K	Buy	+25,000	New	+$156K	﹤0.01%	1311

Other funds holding ANRO

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

SSC

Spruce Street Capital New York $416M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Brown Advisory's ANRO Position: Q1 2026 in Review

Brown Advisory held its Alto Neuroscience (ANRO) position steady in Q1 2026 at 25,000 shares worth $562K. The position accounts for ﹤0.01% of the portfolio, ranked #1020.

Brown Advisory first reported a position in ANRO in Q4 2024 and has held it in 6 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

Brown Advisory held 25,000 shares of Alto Neuroscience worth $562K as of Q1 2026.
Brown Advisory left its Alto Neuroscience share count unchanged in Q1 2026.
Alto Neuroscience made up ﹤0.01% of Brown Advisory's portfolio in Q1 2026, its #1020 holding.
Brown Advisory first reported a position in Alto Neuroscience in Q4 2024 and has held it in 6 quarters since.
110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.